Modern methods of treatment of anaplastic thyroid cancer (clinical case)
Open Access
- 18 September 2026
- journal article
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 16 (2) , 99-108
Abstract
The article presents a clinical case of treating stage IV anaplastic thyroid cancer with a V600E mutation in the BRAF gene and distant metastasis (including metastases to the right ventricle of the heart and the right adrenal gland). At the first stage, targeted therapy (dabrafenib + trametinib) was performed, which allowed achieving pronounced clinico-metabolic regression and performing radical multi-stage surgical treatment. Subsequently, with the development of drug resistance and the detection of high expression of programmed cell death 1 ligand (PD-L1) (Combined Positive Score (CPS) – the ratio of the number of PD-L1-positive cells to the total number of tumor cells = 100), immunotargeted therapy with pembrolizumab in combination with lenvatinib was prescribed, resulting in a partial metabolic response. Despite the subsequent disease progression, overall survival from the time of diagnosis was 46 months. The presented clinical case demonstrates the importance of molecular profiling and the use of a multidisciplinary approach, as well as the possibility of using active surgical management in the oligoprogression of anaplastic thyroid cancer.Keywords
This publication has 7 references indexed in Scilit:
- Anaplastic thyroid cancer: current capabilities of an oncologistHead and Neck Tumors (HNT), 2023
- 1646MO Phase II ATLEP trial: Final results for lenvatinib/pembrolizumab in metastasized anaplastic and poorly differentiated thyroid carcinomaAnnals of Oncology, 2022
- Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket studyAnnals of Oncology, 2022
- Incidence and Mortality Risk Spectrum Across Aggressive Variants of Papillary Thyroid CarcinomaJAMA Oncology, 2020
- Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid CancerThyroid®, 2017
- Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in GermanyEuropean Journal of Endocrinology, 2016
- Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic reviewBMC Surgery, 2013